Bosh sahifaSNG • LON
add
Synairgen plc
Yopilish kursi
4,71 GBX
Kunlik diapazon
4,37 GBX - 4,75 GBX
Yillik diapazon
3,00 GBX - 10,88 GBX
Bozor kapitalizatsiyasi
8,93 mln GBP
Oʻrtacha hajm
162,56 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
LON
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (GBP) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 1,95 mln | -29,14% |
Sof foyda | -1,63 mln | 31,28% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | — | — |
EBITDA | -1,95 mln | 28,75% |
Amaldagi soliq stavkasi | 10,92% | — |
Balans
Jami aktivlari
Jami passivlari
| (GBP) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 8,59 mln | -19,19% |
Jami aktivlari | 10,64 mln | -43,12% |
Jami passivlari | 1,08 mln | -60,69% |
Umumiy kapital | 9,56 mln | — |
Tarqatilgan aksiyalar | 201,37 mln | — |
Narxi/balansdagi bahosi | 0,94 | — |
Aktivlardan daromad | -45,90% | — |
Kapitaldan daromad | -51,07% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (GBP) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,63 mln | 31,28% |
Operatsiyalardan naqd pul | -1,84 mln | 30,36% |
Sarmoyadan naqd pul | 882,00 ming | 88 100,00% |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | -962,50 ming | 63,64% |
Boʻsh pul | -1,13 mln | 24,89% |
Haqida
Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic. The company is developing an inhaled formulation of interferon-beta for severe viral respiratory diseases including COVID-19.
Richard Marsden was appointed chief executive officer in September 2009. Wikipedia
Tashkil etilgan
2003
Sayt
Xodimlar soni
36
